Posturography in MS patients treated with high dose methylprednisolone

References

• Leary SM, Porter B, Thompson AJ. Multiple sclerosis: diagnosis and the management of acute relapses. Postgrad Med J. 2005;81:302–8.10.1136/pgmj.2004.029413
   PubMed Web of Science ®Google Scholar
• Burnham JA, Wright RR, Dreisbach J, Murray RS. The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions. Neurology. 1991;41:1349–54.10.1212/WNL.41.9.1349
   PubMed Web of Science ®Google Scholar
• Whitaker JN, Layton BA, Herman PK, Kachelhofer RD, Burgard S, Bartolucci AA. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment. Ann Neurol. 1993;33:10–7.10.1002/(ISSN)1531-8249
   PubMed Web of Science ®Google Scholar
• Miller DM, Weinstock-Guttman B, Bethoux F, Lee JC, Beck G, Block V, et al. A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult sclera. 2000;6:267–73.10.1177/135245850000600408
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar
• Willoughby EW, Paty DW. Scales for rating impairment in multiple sclerosis: a critique. Neurology. 1988;38:1793–8.10.1212/WNL.38.11.1793
   PubMed Web of Science ®Google Scholar
• Monsell EM, Furman JM, Herdman SJ, Konrad HR, Shepard NT. Computerized dynamic platform posturography. Otolaryngol Head Neck Surg. 1997;117:394–8.10.1016/S0194-5998(97)70132-3
   PubMed Web of Science ®Google Scholar
• Corradini ML, Fioretti S, Leo T, Piperno R. Early recognition of postural disorders in multiple sclerosis through movement analysis: a modeling study. IEEE Trans Biomed Eng. 1997;44:1029–38.10.1109/10.641330
   PubMed Web of Science ®Google Scholar
• Prosperini L, Pozzilli C. The clinical relevance of force platform measures in multiple sclerosis: a review. Mult Scler Int. 2013;2013:756564.
   Google Scholar
• Mattacola CG, Lebsack DA, Perrin DH. Intertester reliability of assessing postural sway using the chattecx balance system. J Athl Train. 1995;30:237–42.
   PubMedGoogle Scholar
• Gandelman-Marton R, Arlazoroff A, Dvir Z. Balance performance in adult epilepsy patients. Seizure. 2006 Dec;15(8):582–9.10.1016/j.seizure.2006.08.002
   PubMed Web of Science ®Google Scholar
• Gandelman-Marton R, Arlazoroff A, Dvir Z. Ocular dominance and balance performance in healthy adults. Gait Posture. 2010Mar.;31(3):394–6.10.1016/j.gaitpost.2009.11.015
   PubMed Web of Science ®Google Scholar
• Ishizaki H, Pyykkö I, Aalto H, Starck J. Repeatability and effect of instruction of body sway. Acta Otolaryngol Suppl. 1991;481:589–92.10.3109/00016489109131478
   PubMedGoogle Scholar
• Sellebjerg F, Barnes D, Filippini G, Midgard R, Montalban X, Rieckmann P, et al. EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol. 2005;12:939–46.10.1111/ene.2005.12.issue-12
   PubMed Web of Science ®Google Scholar
• Patzold T, Schwengelbeck M, Ossege LM, Malin JP, Sindern E. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta Neurol Scand. 2002;105:164–8.10.1034/j.1600-0404.2002.1o135.x
   PubMed Web of Science ®Google Scholar
• Barkhof F, Hommes OR, Scheltens P, Valk J. Quantitative MRI changes in gadolinium – DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology. 1991;41:1219–22.10.1212/WNL.41.8.1219
   PubMed Web of Science ®Google Scholar
• Fierro B, Salemi G, Brighina F, Buffa D, Conte S, La Bua V, et al. A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta Neurol Scand. 2002;105:152–7.10.1034/j.1600-0404.2002.1o369.x
   PubMed Web of Science ®Google Scholar
• Filipović SR, Drulović J, Stojsavljević N, Lević Z. The effects of high-dose intravenous methylprednisolone on event-related potentials in patients with multiple sclerosis. J Neurol Sci. 1997;152:147–53.10.1016/S0022-510X(97)00159-7
   PubMed Web of Science ®Google Scholar
• Greenberg HS, Werness SAS, Pugh JE, Andrus RO, Anderson DJ, Domino EF. Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clin Pharm Therap. 1994;55:324–8.10.1038/clpt.1994.33
   PubMed Web of Science ®Google Scholar
• Prosperini L, Gianno C, Fortuna D, Marchetti MR, Pozzilli C. Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis. Mult Scler Int. 2014;2014:802307.
   PubMedGoogle Scholar
• Parker SW, Lehrich JR. Quantitative serial measurement of standing balance by dynamic posturography to monitor treatment of multiple sclerosis patients (Abstract). Neurology. 1990;40(Suppl 1):140.
   Google Scholar
• Jackson RT, Epstein CM, De l’Aune WR. Abnormalities in posturography and estimations of visual vertical and horizontal in multiple sclerosis. Am J Otol. 1995;16:88–93.
   Google Scholar
• Soyuer F, Mirza M, Erkorkmaz Ü. Balance performance in three forms of multiple sclerosis. Neurol Res. 2006;28:555–62.10.1179/016164105X49373
   PubMed Web of Science ®Google Scholar
• Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E, et al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler. 2006;12:620–8.10.1177/1352458506070658
   PubMed Web of Science ®Google Scholar
• Karst GM, Venema DM, Roehrs TG, Tyler AE. Center of Pressure measures during standing tasks in minimally impaired persons with multiple sclerosis. J Neurol Phys Ther. 2005;29:170–80.10.1097/01.NPT.0000282314.40230.40
   PubMedGoogle Scholar
• Cattaneo D, Jonsdottir J, Repetti S. Reliability of four scales on balance disorders in persons with multiple sclerosis. Disabil Rehabil. 2007;29:1920–5.10.1080/09638280701191859
   PubMed Web of Science ®Google Scholar
• Davide C, Roldano C, Pierpaolo M, Giorgio S. Computerized assessment of voluntary control in the shift of the center of pressure: a pilot study. Neurorehabil Neural Repair. 2000;14:119–26.10.1177/154596830001400204
   PubMed Web of Science ®Google Scholar
• Smith T, Zeeberg I, Sjö O. Evoked potentials in multiple sclerosis before and after high-dose methylprednisolone infusion. Eur Neurol. 1986;25:67–73.10.1159/000115989
   PubMed Web of Science ®Google Scholar
• Özkan S, Uzuner N, Kutlu C, Özbabalik D, Özdemir G. The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis. J Clin Neurosci. 2006;13:214–7.
   PubMed Web of Science ®Google Scholar
• Milligan NM, Newcombe R, Compston DAS. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry. 1987;50:511–6.10.1136/jnnp.50.5.511
   PubMed Web of Science ®Google Scholar